SEC Form 4 · accession 0001683168-17-000765
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul V Maier
Director
Period of report
Mar 31, 2017
Accepted (ET)
Apr 3, 2017 · 1:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 31, 2017 | A | 4,642 | $0.00 | A | 33,060 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q1 2017.